Phân Tích Lai Tạo Tươi Trong Nghiên Cứu Bệnh Bạch Cầu Tủy Mạn Tính Không Có NST Philadelphia Với Gen Ghép bcr/abl

Cortes JE, Talpaz M, Beran M, et al. Philadelphia chromosomenegative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region: long term follow-up results. Cancer. 1995;75:464–470. Takahashi N, Miura I, Ohshima A, et al. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia. Cancer Genet Cytogenet. 1996;89:166–169. Kurzrock R, Blick MD, Talpaz M, et al. Rearrangement in the breakpoint cluster region and the clinical course in Philadelphianegative chronic myelogenous leukemia. Ann Intern Med. 1986;105:673–679. van der Plas DC, Hermans ABC, Soekarman D, et al. Cytogenetic and molecular analysis in Philadelphia negative CML. Blood. 1989;73:1038–1044. Goldman JM, Melo JV. Chronic myeloid leukemia: advances in biology and new approaches to treatment. N Engl J Med. 2003;349:1451–1464. Weinstein ME, Grossman A, Perle MA, et al. The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia. Cancer Genet Cytogenet. 1988;35:223–229. Calabrese G, Stuppia M, Franchi PG, et al. Complex translocation of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet. 1994;78:153–159. Hagemeijer A, Buijs A, Smit E, et al. Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Phnegative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer. 1993;8:237–245. Inazawa J, Nishigaki H, Takahira H, et al. Rejoining between 9q+ and Philadelphia chromosomes results in normal-looking chromosomes 9 and 22 in Ph1-negative chronic myelocytic leukemia. Hum Genet. 1989;83:115–118. Morris CM, Heisterkamp N, Kennedy MA, Fitzgerald PH, Groffen J. Ph-negative chronic myeloid leukemia: molecular analysis of ABL insertion into M-BCR on chromosome 22. Blood. 1990;76:1812–1818. Tanaka K, Minamihisamatu M, Yagi S, et al. Two step mechanism for formation of complex 9;22 chromosome translocation in chronic myelocytic leukemia detected by fluorescence in situ hybridization. Exp Oncol. 2001;23:29–38. Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood. 1984;63:789–799. Hasford J, Pfirrmann M, Hehlmann R, et al. A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa: Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst. 1998;90:850–858. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB. Proposal for simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med. 1990;88:1–8. Nishii K, Usui E, Sakakura M, et al. Additional t(11;17)(q23;q21) in a patient with Philadelphia-positive mixed lineage antigenexpressing leukemia. Cancer Genet Cytogenet. 2001;126:8–12. Talpaz M, Kantarjian HM, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia: Philadelphia chromosome-positive patients. Ann Intern Med. 1991;114:532–538. El-Zimaity MMT, Kantarjian HM, Talpaz M, et al. Results of imatinib mesylate therapy in chronic myelogenous leukemia with variant Philadelphia chromosome. Br J Haematol. 2004;125:187–195. Nishii K, Usui E, Katayama N, et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML. Leukemia. 2003;17:731–737. Osumi K, Fukui T, Kiyoi H, et al. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR. Leuk Lymphoma. 2002;43:2291–2299.